We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Prevalence of Intracranial Aneurysm in Hong Kong Chinese

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01078506
Recruitment Status : Completed
First Posted : March 2, 2010
Last Update Posted : April 23, 2013
Sponsor:
Information provided by (Responsible Party):

February 26, 2010
March 2, 2010
April 23, 2013
January 2010
January 2013   (Final data collection date for primary outcome measure)
Intracranial aneurysm [ Time Frame: Three years ]
Same as current
Complete list of historical versions of study NCT01078506 on ClinicalTrials.gov Archive Site
Other intracranial pathologies [ Time Frame: Three years ]
Same as current
Not Provided
Not Provided
 
Prevalence of Intracranial Aneurysm in Hong Kong Chinese
Prevalence of Intracranial Aneurysm in Hong Kong Chinese
Intracranial aneurysm (localized dilatation in weakened blood vessel wall) rupture is a catastrophic disease, with half of the victims died and many of the survivors disabled. There is currently no data in the literature for the Chinese population concerning the prevalence, characteristics (location and size) and risk of harboring an unruptured intracranial aneurysm. In this study, the investigators aim to study the population prevalence and characteristics (location and size) of intracranial aneurysm in Hong Kong Chinese, and its cost-effectiveness. The screening is carried out using magnetic resonance angiography (MRA), with a 3-T magnetic resonance system, which is a well-established non-invasive method for intracranial aneurysm detection.
As charted below.
Observational
Observational Model: Ecologic or Community
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Hong Kong Chinese without a history of known intracranial pathologies
Intracranial Aneurysm
Not Provided
Hong Kong Chinese
Without a history of known intracranial pathologies.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
200
January 2013
January 2013   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Healthy adults aged between 21 and 65 years

Exclusion Criteria:

  • Contraindications to MRI
  • History of known intracranial pathologies
Sexes Eligible for Study: All
21 Years to 65 Years   (Adult)
Yes
Contact information is only displayed when the study is recruiting subjects
China
 
 
NCT01078506
GW006
Yes
Not Provided
Not Provided
George KC Wong, Chinese University of Hong Kong
Chinese University of Hong Kong
Not Provided
Principal Investigator: George KC Wong Chinese University of Hong Kong
Chinese University of Hong Kong
April 2013